Free Trial

International Biotechnology (LON:IBT) Stock Passes Above 200-Day Moving Average - What's Next?

International Biotechnology logo with Financial Services background

International Biotechnology (LON:IBT - Get Free Report)'s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 659.43 ($8.61) and traded as high as GBX 698 ($9.11). International Biotechnology shares last traded at GBX 682 ($8.91), with a volume of 99,569 shares.

International Biotechnology Trading Up 2.6 %

The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46. The stock has a 50-day simple moving average of GBX 678.77 and a two-hundred day simple moving average of GBX 659.43. The firm has a market cap of £258.72 million, a PE ratio of 1,446.67 and a beta of 0.21.

Insiders Place Their Bets

In other International Biotechnology news, insider Gillian Elcock bought 1,407 shares of the business's stock in a transaction that occurred on Wednesday, July 24th. The stock was purchased at an average price of GBX 709 ($9.26) per share, for a total transaction of £9,975.63 ($13,026.42). Company insiders own 4.18% of the company's stock.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Featured Stories

→ Watch this before it gets removed (From Porter & Company) (Ad)

Should you invest $1,000 in International Biotechnology right now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!

Recent Videos

ISRG Stock Surges: AI and Healthcare Innovation at the Core
Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines